Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • đŸ”„
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Is ALGN Underperforming the Healthcare Sector?
Economy

Is ALGN Underperforming the Healthcare Sector?

Last updated: June 20, 2025 12:50 pm
Share
Is ALGN Underperforming the Healthcare Sector?
SHARE

Align Technology, Inc. (ALGN) is a prominent player in the medical instruments & supplies industry, with a market cap of $12.7 billion. The company, headquartered in Tempe, Arizona, is known for designing, manufacturing, and marketing Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services both in the United States and internationally.

As a large-cap stock, ALGN is among companies valued at $10 billion or more, underscoring its significant size and influence in the market. The company operates through two main segments, Clear Aligner and CAD/CAM Services, offering CAD/CAM digital services used in dentistry, orthodontics, and dental records storage.

Despite reaching a 52-week high of $263.24 on Jul. 18, 2024, ALGN shares have since declined by 31.6%. However, over the past three months, the stock has shown resilience, growing by 9.4%, outperforming the Health Care Select Sector SPDR Fund’s (XLV) decline of 9.3% during the same period.

Over the past year, ALGN shares have experienced a 25.7% decline, compared to XLV’s 8.7% fall. The stock is also down 13.7% year-to-date, underperforming XLV’s 3.2% decline. ALGN shares have been trading below their 200-day moving average for the past year and mostly above their 50-day moving average since late April.

Following the release of its Q1 results on Apr. 30, ALGN shares dropped by 2.5%. The company reported revenue of $979.3 million, surpassing Wall Street forecasts of $972.8 million. Its adjusted EPS of $1.52 also marginally exceeded Wall Street expectations. For Q2, ALGN anticipates revenue in the range of $1.05 billion to $1.07 billion.

In comparison, ALGN’s peer, Solventum Corporation (SOLV), has surged by 10% in 2025 and 36.2% over the past year, outperforming ALGN. Analysts covering ALGN stock have a consensus rating of “Moderate Buy,” with a mean price target of $234.25, suggesting a 30.1% upside potential from current price levels.

See also  Trade Fiscal Policy Drive Defense ETF Gains, Record Flows

It’s important to note that the information provided in this article is purely for informational purposes. The author, Kritika Sarmah, does not hold any positions in the securities mentioned. For more details, the original article can be found on Barchart.com.

TAGGED:ALGNHealthcaresectorunderperforming
Share This Article
Twitter Email Copy Link Print
Previous Article Casino Lights Could Be Warping Your Brain to Take Risks, Scientists Warn : ScienceAlert Casino Lights Could Be Warping Your Brain to Take Risks, Scientists Warn : ScienceAlert
Next Article Suspect with Taser and rope charged in attempted kidnapping of Memphis mayor, police say Suspect with Taser and rope charged in attempted kidnapping of Memphis mayor, police say
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

The Story Behind Sydney Sweeney’s Intergalactic, Britney Spears-Honoring Birthday Dress

Galaxy-Inspired Glamour: Sydney Sweeney's Birthday Dress by The Blonds For her recent galaxy-themed birthday celebration,…

October 1, 2025

US threatens tariffs ‘boomerang’ next month if no deals are struck

Unlock the White House Watch newsletter for free Are you curious about what Trump’s second…

July 6, 2025

Cher’s Addict Son’s Estranged Wife Begs For Cash Handout

Cher's Son Elijah Allman's Divorce Drama: Wife Slams Singer in Conservatorship Battle Marieangela King, the…

July 1, 2025

Why Exosome Skincare Is The Ultimate Anti-Aging Breakthrough We Love

Exploring Style Rave: Your Ultimate Fashion Destination Welcome to Style Rave, where fashion meets creativity!…

September 30, 2025

Kate Beckinsale Sues Canary Black Producers for Negligence

Kate Beckinsale is taking legal action against the producers of her 2024 film, "Canary Black."…

June 12, 2025

You Might Also Like

Market analysts react to Trump-Xi meet
Economy

Market analysts react to Trump-Xi meet

October 31, 2025
29 truck carrier files Chapter 11
Economy

29 truck carrier files Chapter 11

October 31, 2025
Trust Government Statistics, Not Government
Economy

Trust Government Statistics, Not Government

October 31, 2025
Jefferies Raises BP Price Target to 420 GBp, Maintains Hold Rating
Economy

Jefferies Raises BP Price Target to 420 GBp, Maintains Hold Rating

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?